Trial Profile
Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Cryoglobulinaemia; Hepatitis C
- Focus Therapeutic Use
- 02 Aug 2019 Status changed from recruiting to completed.
- 21 Apr 2019 Planned End Date changed from 1 Dec 2018 to 1 Apr 2019.
- 21 Apr 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Apr 2019.